Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A touch of MS: Therapeutic mislabeling.
Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis.
Individual variability in speed of information processing: An index of cognitive impairment in multiple sclerosis.
Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.
Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS.
Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis.
Ampyra (dalfampridine) medication guide
Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target.
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.
Changes in phospholipid composition of the spinal cord in rabbits with allergic encephalomyelitis as an experimental model of multiple sclerosis.
Pregnancy and Multiple Sclerosis (MS): A Beneficial Association. Possible therapeutic application of embryo-specific Pre-implantation Factor (PIF*).
Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature.
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Segway use in individuals with multiple sclerosis.
Variables associated with patient activation in persons with multiple sclerosis.
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS?
Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis.
Oral contraceptive use and clinical outcomes in patients with multiple sclerosis.
Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] (RECYCLINE)
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
160 Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis.
Noninvasive molecular imaging of neuroinflammation.
Distribution of Brain Sodium Accumulation Correlates with Disability in Multiple Sclerosis: A Cross-sectional 23Na MR Imaging Study.
Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
Pages
« first
‹ previous
…
171
172
173
174
175
176
177
178
179
…
next ›
last »